Bladder cancer survival trends are difficult to interpret because of changes to classification and coding practices affecting the definition of invasive carcinoma of the bladder.The decrease in bladder cancer survival since the 1990s is likely to be due to an increasing proportion of bladder tumours now being coded as in situ or uncertain.
One-year
Bladder Cancer (C67), Age-Standardised One-Year Net Survival, Adults (Aged 15-99), England and Wales, 1971-2011
Five-year age-standardised net survival for bladder cancer in men has increased from 41% during 1971-1972 to 63% during 1990-1991 and then decreased to a predicted survival of 57% during 2010-2011 in England and Wales.[1] In women, five-year survival has increased from 35% to 55% and then decreased to 46% over the same time periods.
Bladder Cancer (C67), Age-Standardised Five-Year Net Survival, Adults (Aged 15-99), England and Wales, 1971-2011
Five-year survival for 2010-2011 is predicted using an excess hazard statistical model
Ten-year age-standardised net survival for bladder cancer in men has increased from 34% during 1971-1972 to 54% during 1990-1991 and remained stable at a predicted survival of 54% during 2010-2011 in England and Wales.[1] In women, ten-year survival has increased from 29% to 49% and then decreased to 40% over the same time periods. Overall, half of people diagnosed with bladder cancer today are predicted to survive their disease for at least ten years.
Bladder Cancer (C67), Age-Standardised Ten-Year Net Survival, Adults (Aged 15-99), England and Wales, 1971-2011
Ten-year survival for 2005-2006 and 2010-2011 is predicted using an excess hazard statistical model
About this data
Data is for England and Wales, 1971-2011, ICD-10 C67